Skip to main content
logo
RecensMedical, Inc. (KOSDAQ:394420)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,710.00
+110.00 (1.67%)
At close: Oct 21, 2026

RecensMedical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
6,5218,8296,2595,771281.76
Revenue Growth
4.17%41.05%8.47%1948.03%-
Gross Profit
3,4724,3091,3433,00691.91
Operating Income
-11,742-10,640-14,161-12,584-20,245
Net Income
-11,046-19,119-7,844-7,572-40,994
Earnings Per Share
-1126.10-2890.00-2292.00-2282.91-12412.11
EPS Growth
-----

Revenue by Geography
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
South Korea
1,7232,2491,6523,584217.46
Asia
2,9713,3121,7551,43416.55
USA
710.21,7661,823435.79-
Others
354.66739.56855.36317.0447.75
Europe
-762.11173.44--
Total
6,5218,8296,2595,771281.76

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
13,672987.5110,2962,57116,434
Total Debt
5,976804.72617.61778.61973.09
Net Cash (Debt)
7,696182.799,6791,79315,460
Net Cash Growth
-20.49%-98.11%439.95%-88.41%-
Net Cash Per Share
784.5927.632828.22540.424681.06

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-11,266-8,594-9,733-13,278-22,022
Capital Expenditures
-1,136-760.59-482.58-251.62-717.77
Free Cash Flow
-12,402-9,354-10,215-13,530-22,740
Free Cash Flow Growth
-----

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
53.25%48.81%21.46%52.09%32.62%
Operating Margin
-180.08%-120.52%-226.24%-218.07%-7185.17%
Pretax Margin
-169.40%-216.56%-125.31%-131.22%-14549.34%
Profit Margin
-169.40%-216.56%-125.31%-131.22%-14549.34%
FCF Margin
-190.19%-105.95%-163.20%-234.47%-8070.77%